View More View Less
  • 1 Novartis Pharma AG, Fabrikstrasse 14, 4002 Basel, Switzerland
Restricted access

This work describes the manufacturing of ribociclib following the concept of an end-to-end continuous-flow process. The active pharmaceutical ingredient (API) is produced in a two-step telescoped flow process with integrated in-line liquid—liquid extraction and semibatch crystallization.

Supplementary Materials

    • Supplementary Material